Henry Hoppe

Corporate Officer/Principal en Xenetic Biosciences (UK) Ltd. .

Health Technology

Finance

Perfil

Henry Hoppe is currently the Vice President-Drug Development at Xenetic Biosciences (UK) Ltd.
He received his undergraduate and doctorate degrees from Massachusetts Institute of Technology in 1980.

Cargos activos de Henry Hoppe

Empresas	Cargo	Inicio
Xenetic Biosciences (UK) Ltd. Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom.	Corporate Officer/Principal	14/05/2012

Todos los cargos activos de Henry Hoppe

Formación de Henry Hoppe.

Massachusetts Institute of Technology

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Henry Hoppe.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Xenetic Biosciences (UK) Ltd. Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom.	Health Technology